Prospects and Trends in the Brazilian Market for Biologically Sourced Products

The aim of this paper was to select the most interesting Brazilian biopharmaceuticals, with the best market opportunity for production. The biopharmaceuticals filgrastim, infliximab, somatropin, imiglucerase, betainterferon and factor VIII were selected because they are not produced in Brazil and th...

Full description

Bibliographic Details
Main Authors: Luciana da Silva Madeira, Suzana Borschiver, Nei Pereira Jr
Format: Article
Language:English
Published: Universidad Alberto Hurtado 2012-09-01
Series:Journal of Technology Management & Innovation
Subjects:
Online Access:https://www.jotmi.org/index.php/GT/article/view/904